We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

009150:KRXSamsung Electro-Mechanics Co., Ltd Analysis

Data as of 2026-05-18 - not real-time

₩1,031,000.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Samsung Electro‑Mechanics is riding a robust earnings wave, with revenue climbing at a double‑digit pace and operating profit expanding sharply. Technical signals are bullish: the price sits comfortably above the short‑ and medium‑term moving averages, the MACD line sits above its signal, and volume is on an upward trend. However, the RSI has surged into overbought territory, and the stock is flirting with a key resistance level that aligns with its recent 52‑week high, suggesting a possible short‑term pullback. Market sentiment is at an extreme greed peak, and the fear‑greed gauge reflects a highly optimistic investor mood.
On the valuation side, the market price is well above the discounted cash‑flow estimate, indicating a stretched multiple despite a forward PE that mirrors the industry average. The balance sheet carries a high debt load relative to equity, though cash reserves are ample and the dividend payout is modest, supporting dividend sustainability. Margins remain modest, and free cash flow is barely negative, which tempers the growth story. Considering the blend of strong earnings momentum, elevated valuation, and heightened volatility, the outlook calls for cautious positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical resistance
  • RSI in overbought zone
  • strong recent earnings beat

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • sustained revenue growth
  • analyst consensus strong‑buy
  • moderate dividend yield

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high debt relative to equity
  • valuation above DCF estimate
  • stable market position in electronic components

Key Metrics & Analysis

Financial Health

Revenue Growth16.40%
Profit Margin6.24%
P/E Ratio38.8
ROE7.78%
ROA4.17%
Debt/Equity23.24
Op. Cash Flow₩1490.1B
Free Cash Flow₩-1814668544
Industry P/E38.4

Technical Analysis

TrendBullish
RSI82.1
Support₩642,000.00
Resistance₩1,133,000.00
MA 20₩870,500.00
MA 50₩627,550.00
MA 200₩333,196.00
MACDBullish
VolumeIncreasing
Fear & Greed Index88.2

Valuation

Fair Value₩364,894.28
Target Price₩1,054,814.90
Upside/Downside2.31%
GradeOvervalued
TypeGrowth
Dividend Yield0.23%

Risk Assessment

Beta1.13
Volatility69.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.